This inventor holds 6 USPTO granted patents and 2 EPO patents. Top assignee: Unichem Laboratories Limited. Active years: 2018-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2024
Title: Yashwant S Surve: Innovator in Pharmaceutical Chemistry
Introduction
Yashwant S Surve is a prominent inventor based in Maharashtra, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the synthesis of important medications. With a total of six patents to his name, Surve has demonstrated a commitment to innovation and improvement in drug development.
Latest Patents
Among his latest patents is a process for the preparation of Rivaroxaban involving a novel intermediate. This invention relates to the key intermediate, 4-{4-[(SS)-(Aminomethyl)-2-oxo-1,3-oxazolidin-3-yl]-phenyl}-morpholin-3-one perchlorate, which plays a crucial role in the synthesis of Rivaroxaban. The invention also covers the crystalline form of this novel intermediate, the process to prepare it, and the method of preparing Rivaroxaban using this intermediate. This innovative approach provides an improved and efficient process for the preparation of Rivaroxaban.
Career Highlights
Yashwant S Surve is currently associated with Unichem Laboratories Limited, where he continues to work on advancing pharmaceutical technologies. His expertise in the field has led to the development of several key processes that enhance the efficiency of drug synthesis.
Collaborations
Surve has collaborated with notable colleagues, including Dhananjay Govind Sathe and Arijit Das. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Yashwant S Surve is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in drug synthesis. His contributions, particularly in the development of Rivaroxaban, highlight his dedication to improving healthcare through innovative solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile